Get the Stockscreener App
39.45
0.97%
0.38
After Hours:
39.45
Phibro Animal Health Corp stock is traded at $39.45, with a volume of 473.63K.
It is up +0.97% in the last 24 hours and up +48.36% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$39.07
Open:
$39
24h Volume:
473.63K
Relative Volume:
1.53
Market Cap:
$803.50M
Revenue:
$982.01M
Net Income/Loss:
$14.80M
P/E Ratio:
106.62
EPS:
0.37
Net Cash Flow:
$37.02M
1W Performance:
+6.42%
1M Performance:
+48.36%
6M Performance:
+67.80%
1Y Performance:
+103.14%
1-Day Range:
$38.81
$39.88
1-Week Range:
$34.65
$39.91
52-Week Range:
$16.16
$39.91
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
39.45 | 1.58B | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-16-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
What momentum shifts mean for Phibro Animal Health Corporation2025 Historical Comparison & Growth Focused Investment Plans - Newser
How high can Phibro Animal Health Corporation stock go2025 Year in Review & High Accuracy Trade Alerts - Newser
Sentiment analysis tools applied to Phibro Animal Health CorporationDividend Hike & Smart Money Movement Alerts - Newser
Understanding Phibro Animal Health Corporation’s price movement2025 Price Momentum & Expert Approved Trade Ideas - Newser
Phibro Animal Health stock price target raised to $37 by BNP Paribas - Investing.com
BNP Paribas Hikes Price Target on Phibro Animal Health to $37 From $24, Maintains Neutral Rating - MarketScreener
Phibro Animal Health stock hits 52-week high at 38.84 USD - Investing.com
Jobs Data: What’s the fair value of Phibro Animal Health Corporation stock2025 Top Gainers & Advanced Swing Trade Entry Alerts - خودرو بانک
Phibro Animal Health Corporation stock outlook for YEAR2025 Trading Recap & Reliable Breakout Forecasts - Newser
Is Phibro Animal Health Corporation showing insider buyingJuly 2025 WrapUp & AI Driven Price Predictions - خودرو بانک
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference - Yahoo Finance
Multi asset correlation models including Phibro Animal Health CorporationJuly 2025 Market Mood & Real-Time Buy Signal Notifications - Newser
Ex-Dividend Reminder: Home Depot, Phibro Animal Health and Cigna - Nasdaq
Phibro Animal Health's Acquisition of Zoetis' Medicated Feed Additive Spurs 53% YoY Growth - AInvest
Multi factor analysis applied to Phibro Animal Health CorporationJuly 2025 Weekly Recap & Community Supported Trade Ideas - Newser
Wall Street Recap: What’s the fair value of Phibro Animal Health Corporation stockMarket Activity Recap & Weekly Watchlist for Hot Stocks - خودرو بانک
Institutional scanner results for Phibro Animal Health CorporationQuarterly Portfolio Report & Advanced Swing Trade Entry Plans - Newser
Is Phibro Animal Health Corporation still worth holding after the dipMarket Trend Report & Weekly Stock Breakout Alerts - Newser
Custom strategy builders for tracking Phibro Animal Health Corporation2025 Earnings Impact & Momentum Based Trading Ideas - Newser
Unlocking Phibro (PAHC) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
Wellington Management Group LLP Sells 18,885 Shares of Phibro Animal Health Corporation $PAHC - Defense World
Phibro Animal Health Corp’s Earnings Call Highlights Robust Growth - TipRanks
Market reaction to Phibro Animal Health Corporation’s recent newsStop Loss & Precise Swing Trade Alerts - Newser
Phibro Animal Health Corporation stock volume spike explainedInsider Buying & Reliable Breakout Forecasts - Newser
What’s the recovery path for long term holders of Phibro Animal Health Corporation2025 Bull vs Bear & Daily Oversold Bounce Ideas - Newser
Here's What We Like About Phibro Animal Health's (NASDAQ:PAHC) Upcoming Dividend - ca.finance.yahoo.com
Analyzing drawdowns of Phibro Animal Health Corporation with statistical toolsJuly 2025 Recap & Expert Curated Trade Ideas - Newser
Full technical analysis of Phibro Animal Health Corporation stockWatch List & Safe Entry Point Identification - Newser
Dividend and Recent Updates on Phibro Animal Health: Everything You Need to Know Before the Sep 3, 2025 Ex-Dividend Date - AInvest
Statistical indicators supporting Phibro Animal Health Corporation’s strengthJuly 2025 Fed Impact & Low Drawdown Investment Strategies - Newser
Phibro Animal Health Corporation Q4 2025 Earnings Call Transcript Highlights - AInvest
Deutsche Bank AG Decreases Stake in Phibro Animal Health Corporation $PAHC - Defense World
Volatility clustering patterns for Phibro Animal Health CorporationRecession Risk & Low Risk High Reward Ideas - Newser
Phibro Animal Health Faces AI-Driven Risks Threatening Business Stability - TipRanks
Applying Wyckoff theory to Phibro Animal Health Corporation stockJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Newser
Automated trading signals detected on Phibro Animal Health CorporationJuly 2025 Snapshot & Daily Risk Controlled Trade Plans - Newser
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):